Cardioprotection: definition, classification, and fundamental principles.
作者信息
Kübler W, Haass M
机构信息
Department of Cardiology, University of Heidelberg, Germany.
出版信息
Heart. 1996 Apr;75(4):330-3. doi: 10.1136/hrt.75.4.330.
Abstract
摘要
相似文献
1
Cardioprotection: definition, classification, and fundamental principles.心脏保护：定义、分类及基本原理。
Heart. 1996 Apr;75(4):330-3. doi: 10.1136/hrt.75.4.330.
2
The Role of Angiotensin-Converting Enzyme Inhibitors and β-Blockers in Primary Prevention of Cardiac Dysfunction in Breast Cancer Patients.血管紧张素转换酶抑制剂和β受体阻滞剂在乳腺癌患者心脏功能障碍一级预防中的作用
J Am Heart Assoc. 2020 Jan 21;9(2):e015327. doi: 10.1161/JAHA.119.015327.
3
4
2000--a time to reflect, look forward, look back and worry about funding.2000年——一个反思、展望、回顾并担忧资金问题的时刻。
Int J Clin Pract. 2000 Jan-Feb;54(1):3.
5
6
[Cardiac insufficiency: strength for the weak heart].[心脏功能不全：为虚弱心脏注入力量]
Dtsch Med Wochenschr. 2005 Oct 28;Suppl 1:29-30.
7
8
Optimal medical therapy use among patients receiving implantable cardioverter/defibrillators: insights from the National Cardiovascular Data Registry.接受植入式心脏复律除颤器治疗的患者中最佳药物治疗的应用：来自国家心血管数据注册库的见解。
Arch Intern Med. 2012 Jan 9;172(1):64-7. doi: 10.1001/archinternmed.2011.466. Epub 2011 Nov 14.
9
What to expect from ACE inhibitors after myocardial infarction.心肌梗死后使用血管紧张素转换酶抑制剂的预期效果
Br Heart J. 1994 Sep;72(3 Suppl):S70-4. doi: 10.1136/hrt.72.3_suppl.s70.
10
Cardiac monitoring and treatment for children and adolescents with neuromuscular disorders.针对患有神经肌肉疾病的儿童和青少年的心脏监测与治疗。
Dev Med Child Neurol. 2006 Mar;48(3):164. doi: 10.1017/S0012162206000363.
引用本文的文献
1
S-nitrosylation of cardiac myocyte proteins may underlie sex differences in cardiac disease.心肌细胞蛋白的S-亚硝基化可能是心脏疾病性别差异的潜在原因。
Front Physiol. 2025 May 6;16:1565917. doi: 10.3389/fphys.2025.1565917. eCollection 2025.
2
Catestatin in Cardiovascular Diseases.心血管疾病中的降钙素抑制肽
Int J Mol Sci. 2025 Mar 7;26(6):2417. doi: 10.3390/ijms26062417.
3
Mitochondrial calcium in cardiac ischemia/reperfusion injury and cardioprotection.心肌缺血/再灌注损伤与心脏保护中的线粒体钙
Basic Res Cardiol. 2024 Aug;119(4):569-585. doi: 10.1007/s00395-024-01060-2. Epub 2024 Jun 19.
4
Cardioprotective Effect of Hydroalcohol Extract of Andaliman ( DC.) Fruits on Doxorubicin-Induced Rats.山柰（DC.）果实水醇提取物对阿霉素诱导大鼠的心脏保护作用
Pharmaceuticals (Basel). 2024 Mar 10;17(3):359. doi: 10.3390/ph17030359.
5
Health position paper and redox perspectives on reactive oxygen species as signals and targets of cardioprotection.健康立场文件及活性氧作为心脏保护的信号和靶点的氧化还原观点。
Redox Biol. 2023 Nov;67:102894. doi: 10.1016/j.redox.2023.102894. Epub 2023 Oct 6.
6
Antioxidant Flavonoid Diosmetin Is Cardioprotective in a Rat Model of Myocardial Infarction Induced by Beta 1-Adrenergic Receptors Activation.抗氧化类黄酮香叶木素在β1-肾上腺素能受体激活诱导的大鼠心肌梗死模型中具有心脏保护作用。
Curr Issues Mol Biol. 2023 May 29;45(6):4675-4686. doi: 10.3390/cimb45060297.
7
Juglone from Walnut Produces Cardioprotective Effects against Isoproterenol-Induced Myocardial Injury in SD Rats.核桃中的胡桃醌对异丙肾上腺素诱导的SD大鼠心肌损伤具有心脏保护作用。
Curr Issues Mol Biol. 2022 Jul 16;44(7):3180-3193. doi: 10.3390/cimb44070220.
8
Protective Effects of Sauropus Androgynus Leaf Extract against Isoproterenol Induced Cardiotoxicity.守宫木叶提取物对异丙肾上腺素诱导的心脏毒性的保护作用。
Cardiovasc Toxicol. 2022 Jun;22(6):579-591. doi: 10.1007/s12012-022-09739-5. Epub 2022 Apr 15.
9
Immunosuppression of Macrophages Underlies the Cardioprotective Effects of CST (Catestatin).CST（卡斯特atin）的心肌保护作用机制与巨噬细胞的免疫抑制有关。
Hypertension. 2021 May 5;77(5):1670-1682. doi: 10.1161/HYPERTENSIONAHA.120.16809. Epub 2021 Apr 7.
10
Renal and Neurologic Benefit of Levosimendan Dobutamine in Patients With Low Cardiac Output Syndrome After Cardiac Surgery: Clinical Trial FIM-BGC-2014-01.左西孟旦与多巴酚丁胺对心脏手术后低心排血量综合征患者肾脏和神经功能的益处：FIM-BGC-2014-01临床试验
Front Pharmacol. 2020 Aug 26;11:1331. doi: 10.3389/fphar.2020.01331. eCollection 2020.
本文引用的文献
1
Changes in myocardial and vascular receptors in heart failure.心力衰竭时心肌和血管受体的变化。
J Am Coll Cardiol. 1993 Oct;22(4 Suppl A):61A-71A. doi: 10.1016/0735-1097(93)90465-d.
2
Preconditioning: state of the art myocardial protection.预处理：心肌保护的前沿技术。
Cardiovasc Res. 1993 Apr;27(4):542-50. doi: 10.1093/cvr/27.4.542.
3
Prognosis in congestive heart failure.
Annu Rev Med. 1994;45:341-50. doi: 10.1146/annurev.med.45.1.341.
4
Signal transduction in myocardial ischaemia.心肌缺血中的信号转导
Eur Heart J. 1994 Apr;15(4):437-45. doi: 10.1093/oxfordjournals.eurheartj.a060523.
5
Release of endogenous catecholamines in the ischemic myocardium of the rat. Part B: Effect of sympathetic nerve stimulation.大鼠缺血心肌中内源性儿茶酚胺的释放。B部分：交感神经刺激的作用。
Circ Res. 1984 Nov;55(5):702-6. doi: 10.1161/01.res.55.5.702.
6
Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure.血浆去甲肾上腺素作为慢性充血性心力衰竭患者预后的一项指标。
N Engl J Med. 1984 Sep 27;311(13):819-23. doi: 10.1056/NEJM198409273111303.
7
Coronary physiology.冠状动脉生理学
Physiol Rev. 1983 Jan;63(1):1-205. doi: 10.1152/physrev.1983.63.1.1.
8
Presynaptic receptors.突触前受体
Annu Rev Pharmacol Toxicol. 1981;21:7-30. doi: 10.1146/annurev.pa.21.040181.000255.
9
Agonist-induced desensitization of the beta-adrenergic receptor-linked adenylate cyclase.激动剂诱导的β-肾上腺素能受体偶联腺苷酸环化酶脱敏
Pharmacol Rev. 1983 Mar;35(1):5-32.
10
Zotero 插件